Table 3.
68Ga-PSMA-11 PET findings
| Characteristic | Patients |
|---|---|
| miTNM classification, no. (%), n = 186 | |
| miT status | |
| 2u | 73 (39.2%) |
| 2m | 52 (28%) |
| 3a | 27 (14.5%) |
| 3b | 24 (12.9%) |
| 4 | 10 (5.4%) |
| miN status | |
| 0 | 168 (90.3%) |
| 1 | 7 (3.8%) |
| 2 | 11 (5.9%) |
| miM status | |
| 0 | 179 (96.2%) |
| 1a | 3 (1.6%) |
| 1b | 4 (2.2%) |
| PSMA-PET findings of prostatic lesions, median (IQR), n = 183a | |
| SUVmax | 10.6 (6.4–18.9) |
| SUVmean | 6.2 (3.2–11.0) |
| TV | 3.9 (1.7–10.5) |
| TL | 24.7 (15.9–44.4) |
IQR interquartile range, PET positron emission tomography, PSMA prostate-specific membrane antigen, SUV standardized uptake value, TL total lesion, TV tumor volume
aThree patients had PSMA negative prostate cancer. miTNM of these patients were classified based on MRI images